Indications |
Intravenous Mild to moderate nasal diphtheria Adult: 10 000-20 000 units via slow IV infusion. Intravenous Mild to moderate tonsillar diphtheria Adult: 15 000-25 000 units via slow IV infusion. Intravenous Mild to moderate pharyngeal or laryngeal diphtheria Adult: 20 000-40 000 units via slow IV infusion. Intravenous Mild to moderate cutaneous diphtheria Adult: Only used if ulcer >2 cm2 (insufficiently absorbed in smaller ulcers). Dose: 20 000-40 000 units by slow IV infusion. Intravenous Severe diphtheria Adult: Up to 100 000 units by slow IV infusion. Intradermal Diphtheria hypersensitivity test Adult: 0.1 ml of diphtheria antitoxin (equine) in 0.9% sodium chloride in a 1:100 dilution. Skin test read 20 minutes later. If patient has a history of allergy: 0.05 ml of a 1:1000 dilution. An inj of 0.9% sodium chloride can be used as a control. A positive reaction is represented by an urticarial wheal, with or without pseudopods, with a zone of erythema. Subconjunctival Diphtheria hypersensitivity test Adult: 1 drop of a 1:10 dilution of equine diphtheria antitoxin administered to lower conjunctival sac of 1 eye, control test of 0.9% sodium chloride administered to other eye. Test read after 15 minutes. A positive test is represented by ocular itching, burning, redness and lacrimation which can be relieved by applying 1 drop of ocular epinephrine solution on the affected eye. Subcutaneous Desensitisation of diphtheria hypersensitivity Adult: Diphtheria antitoxin (equine) is administered in incremental doses every 15 minutes: 0.05 ml of a 1:20 dilution, 0.1 ml of 1:10 dilution, 0.3 ml of a 1:10 dilution and 0.1 ml of undiluted antitoxin. After another 15 minutes, 0.5 ml of undiluted antitoxin is administered IM or IV. Topical/Cutaneous Scratch skin test for diphtheria hypersensitivity Adult: 1 drop of a 1:100 dilution of equine diphtheria antitoxin placed on the skin and then a 0.64 cm scratch made through the drop. A control of 0.9% sodium chloride can be used. Test read after 20 minutes. A positive reaction is represented by an urticarial wheal, with or without pseudopods, with a zone of erythema. |
Contraindications |
Hypersensitivity. |
Warnings / Precautions |
History of asthma. Test doses should be administered before immunisation to eliminate hypersensitivity. Adrenaline inj and resuscitation facilities should be available after all immunisation. Not used for diphtheria prophylaxis because of hypersensitivity risk. A negative sensitivity test dose so not completely exclude systemic sensitivity. If hypersensitivity occurs during or immediately after desensitisation procedure, a tourniquet should be applied and adrenaline administered next to the site of inj. |
Adverse Reactions |
Serum sickness (type III hypersensitivity reaction) up to 12 days after antitoxin admin, symptoms include: Urticaria, fever, pruritus, malaise, skin rash and arthralgia. Accelerated serum sickness (occurring <7 days after immunisation) may occur in individuals with previous admin of equine serum. Potentially Fatal: Anaphylactic reactions (type I hypersensitivity reaction): Sudden onset of urticaria, respiratory distress, hypotension, shock and vascular collapse. |
Mechanism of Actions |
Diptherias antitoxin is used, often concurrently with an antibiotic, for passive immunisation against suspected diphtheria infection. It contains specific globulins which negate the local and systemic effects of toxins produced by Corynebacterium diptheriae. |
Storage Conditions |
Intradermal: Store at 2-8 °C, do not freeze. Intravenous: Store at 2-8 °C, do not freeze. Subconjunctival: Store at 2-8 °C, do not freeze. Subcutaneous: Store at 2-8 °C, do not freeze. Topical/Cutaneous: Store at 2-8 °C, do not freeze. |
ATC Classification |
J06AA01 - diphtheria antitoxin ; Belongs to the class of immune sera. Used in the treatment of acute infectious diseases caused by toxigenic strains. |
Storage |
Intradermal: Store at 2-8 °C, do not freeze. Intravenous: Store at 2-8 °C, do not freeze. Subconjunctival: Store at 2-8 °C, do not freeze. Subcutaneous: Store at 2-8 °C, do not freeze. Topical/Cutaneous: Store at 2-8 °C, do not freeze. |
Available As |
|
Diptheria Immeune Globulin
Post Review about Diptheria Immeune Globulin Click here to cancel reply.
Diptheria Immeune Globulin Containing Brands
Diptheria Immeune Globulin is used in following diseases
Drug - Drug Interactions of Diptheria Immeune Globulin
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.